UNRAVELLING THE PROTECTIVE PATHWAYS OF THE SGLT2I AND GLP-1RA IN DIABETIC KIDNEY DISEASE: ROLE OF THE MAP17 AND D-AKAP-2 SCAFFOLDER PROTEINS IN DB/DB MICE AND IN HUMAN KIDNEY ORGANOIDS